Valneva has been awarded funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and EU to expand access to its recently approved vaccine for chikungunya, a potentially life ...
VALNEVA Declaration of shares and voting rights February 28, 2025_____ Company name: VALNEVARegistered office ...
Valneva has bolstered its vaccines pipeline with a shot designed to protect against shigellosis – a major global health threat – licensed from LimmaTech Biologics. The French pharma company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback